XML 42 R33.htm IDEA: XBRL DOCUMENT
v3.23.1

Acquisitions and Divestitures (Narrative) (Details) $ / shares in Units, $ in Millions | 1 Months Ended | 3 Months Ended
--- | --- | ---
Apr. 30, 2023 USD ($) | Dec. 31, 2022 USD ($) right $ / shares | Feb. 28, 2022 USD ($) | Mar. 31, 2023 USD ($) | Mar. 31, 2022 USD ($)
Business Acquisition [Line Items] |  |  |  |  |
Acquired in-process research and development (Note 3) |  |  |  | $ 105.0 | $ 165.6
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Olanzapine Portfolio | Subsequent Event |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Cash proceeds | $ 1,050.0 |  |  |  |
Additional cash proceeds | 305.0 |  |  |  |
Milestone payment received | 50.0 |  |  |  |
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Baqsimi® | Subsequent Event |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Cash proceeds | 500.0 |  |  |  |
Additional cash proceeds | 125.0 |  |  |  |
Milestone payment received | $ 450.0 |  |  |  |
BioMarin Pharmaceutical Inc |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Acquired IPR&D expense |  |  | $ 110.0 |  |
Akouos Acquisition |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business acquisition, share price (in dollars per share) | $ / shares |  | $ 12.50 |  |  |
Cash paid, net of cash acquired |  | $ 327.2 |  |  |
Consideration transferred, number of contingent value rights | right |  | 1,000,000 |  |  |
Contingent value right, additional price per share (up to) (in dollars per share) | $ / shares |  | $ 3,000,000.00 |  |  |
Contingent value right, additional price per share, aggregate amount |  | $ 122.0 |  |  |

X
- Definition The amount of expense related to research and development that are acquired directly in a transaction other than a business combination, that do not have an alternative future use and are therefore written off in the period of acquisition + References No definition available. + Details
Name: | lly_AcquiredInProcessResearchAndDevelopment
Namespace Prefix: | lly_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Business Acquisition, Contingent Value Right, Additional Price Per Share + References No definition available. + Details
Name: | lly_BusinessAcquisitionContingentValueRightAdditionalPricePerShare
Namespace Prefix: | lly_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Combination, Consideration Transferred, Number Of Contingent Value Rights + References No definition available. + Details
Name: | lly_BusinessCombinationConsiderationTransferredNumberOfContingentValueRights
Namespace Prefix: | lly_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disposal Group, Including Discontinued Operation, Milestone Payments To Be Received + References No definition available. + Details
Name: | lly_DisposalGroupIncludingDiscontinuedOperationMilestonePaymentsToBeReceived
Namespace Prefix: | lly_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payments for Asset Acquisitions + References No definition available. + Details
Name: | lly_PaymentsForAssetAcquisitions
Namespace Prefix: | lly_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation. + References No definition available. + Details
Name: | us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromDivestitureOfBusinesses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=lly_OlanzapinePortfolioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=lly_BaqsimiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=lly_BioMarinPharmaceuticalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lly_AkouosAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |